Suppr超能文献

阐明硫酸乙酰肝素酶2与硫酸乙酰肝素结合的后果。

Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2.

作者信息

Gross-Cohen Miriam, Feld Sari, Arvatz Gil, Ilan Neta, Vlodavsky Israel

机构信息

Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel.

出版信息

Front Oncol. 2021 Jan 29;10:627463. doi: 10.3389/fonc.2020.627463. eCollection 2020.

Abstract

Unlike the intense research effort devoted to exploring the significance of heparanase in human diseases, very little attention was given to its close homolog, heparanase 2 (Hpa2). The emerging role of Hpa2 in a rare autosomal recessive congenital disease called urofacial syndrome (UFS), clearly indicates that Hpa2 is not a pseudogene but rather a gene coding for an important protein. Hpa2 lacks the heparan sulfate (HS)-degrading activity typical of heparanase, yet exhibits high affinity to HS, affinity that is 10-fold higher than that of heparanase. The consequences of this high-affinity interaction of Hpa2 with plasma membrane HSPG has not been explored yet. Here, we used highly purified Hpa2 protein to examine this aspect. We provide evidence that cells adhere to and spread on dishes coated with Hpa2. We also show that cell migration is attenuated markedly by exogenous addition of Hpa2 to primary and transformed cells, a function that agrees with the anti-cancer properties of Hpa2. Interestingly, we found that exogenous addition of Hpa2 also disrupts the morphology of cell colonies, resulting in cell scattering. This implies that under certain conditions and experimental settings, Hpa2 may exhibit pro-tumorigenic properties. We further developed a panel of anti-Hpa2 monoclonal antibodies (mAb) and show that these properties of Hpa2 are prevented by some of the newly-developed mAb, thus providing new molecular tools to better appreciate the significance of Hpa2 in health and disease.

摘要

与致力于探索乙酰肝素酶在人类疾病中意义的大量研究工作不同,其紧密同源物乙酰肝素酶2(Hpa2)却很少受到关注。Hpa2在一种罕见的常染色体隐性先天性疾病——尿路颜面综合征(UFS)中所起的新作用,清楚地表明Hpa2不是一个假基因,而是一个编码重要蛋白质的基因。Hpa2缺乏乙酰肝素酶典型的硫酸乙酰肝素(HS)降解活性,但对HS表现出高亲和力,其亲和力比乙酰肝素酶高10倍。Hpa2与质膜硫酸乙酰肝素蛋白聚糖(HSPG)这种高亲和力相互作用的后果尚未得到探索。在此,我们使用高度纯化的Hpa2蛋白来研究这一方面。我们提供的证据表明,细胞能黏附于涂有Hpa2的培养皿并在其上铺展。我们还表明,向原代细胞和转化细胞中外源添加Hpa2会显著减弱细胞迁移,这一功能与Hpa2的抗癌特性相符。有趣的是,我们发现外源添加Hpa2还会破坏细胞集落的形态,导致细胞散射。这意味着在某些条件和实验设置下,Hpa2可能表现出促肿瘤特性。我们进一步研制了一组抗Hpa2单克隆抗体(mAb),并表明其中一些新研制的mAb可阻止Hpa2的这些特性,从而提供了新的分子工具,以便更好地理解Hpa2在健康和疾病中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/7879983/0e6f4a168e31/fonc-10-627463-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验